Cargando…

Coronavirus Disease 2019: Clinics, Treatment, and Prevention

The coronavirus disease 2019 (COVID-19) pandemic, caused by a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in China and affected the entire world population, either by infection and its health consequences, or by restrictions in daily life as a conse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burkert, Francesco Robert, Lanser, Lukas, Bellmann-Weiler, Rosa, Weiss, Günter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631905/ https://www.ncbi.nlm.nih.gov/pubmed/34858373 http://dx.doi.org/10.3389/fmicb.2021.761887

Ejemplares similares

Markers of Infection-Mediated Cardiac Damage in Influenza and COVID-19
por: Burkert, Francesco Robert, et al.
Publicado: (2022)

Dynamics in Anemia Development and Dysregulation of Iron Homeostasis in Hospitalized Patients with COVID-19
por: Lanser, Lukas, et al.
Publicado: (2021)

Neopterin Predicts Disease Severity in Hospitalized Patients With COVID-19
por: Bellmann-Weiler, Rosa, et al.
Publicado: (2020)

Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients
por: Thommes, Lis, et al.
Publicado: (2021)

Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values
por: Lanser, Lukas, et al.
Publicado: (2020)

Testosterone Deficiency Is a Risk Factor for Severe COVID-19
por: Lanser, Lukas, et al.
Publicado: (2021)

Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection
por: Bellmann-Weiler, Rosa, et al.
Publicado: (2020)

Case report of a COVID-19-associated myocardial infarction with no obstructive coronary arteries: the mystery of the phantom embolus or local endothelitis
por: Burkert, Francesco Robert, et al.
Publicado: (2021)

Rapid antigen testing and non-infectious shedding of SARS-Cov2
por: Weiss, Günter, et al.
Publicado: (2021)

Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis—Mechanistic Insights into Anemia of Inflammation and Its Treatment
por: Lanser, Lukas, et al.
Publicado: (2021)

Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID‐19 inpatients
por: Haschka, David, et al.
Publicado: (2022)

Neopterin is Associated with Disease Severity and Outcome in Patients with Non-Ischaemic Heart Failure
por: Lanser, Lukas, et al.
Publicado: (2019)

Single-Center Experience in Detecting Influenza Virus, RSV and SARS-CoV-2 at the Emergency Department
por: Nairz, Manfred, et al.
Publicado: (2023)

Tularemia Goes West: Epidemiology of an Emerging Infection in Austria
por: Seiwald, Stefanie, et al.
Publicado: (2020)

Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?
por: Weiskirchen, Ralf
Publicado: (2020)

1.5-T MR relaxometry in quantifying splenic and pancreatic iron: retrospective comparison of a commercial 3D-Dixon sequence and an established 2D multi-gradient echo sequence
por: Plaikner, Michaela, et al.
Publicado: (2023)

Microbial and human transcriptional profiling of coronavirus disease 2019 patients: Potential predictors of disease severity
por: Gan, Hairun, et al.
Publicado: (2022)

Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients
por: Choi, Hyun-Woo, et al.
Publicado: (2022)

Comparison of the Performance of 24 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in the Diagnosis of Coronavirus Disease 2019 Patients
por: Wu, Shiji, et al.
Publicado: (2022)

Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review
por: Mehta, Jyoti, et al.
Publicado: (2022)

Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
por: Shapiro, Leland, et al.
Publicado: (2023)

Insights Into the Changing Landscape of Coronavirus Disease 2019
por: Escobedo, Ruby A., et al.
Publicado: (2022)

Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City, China
por: Liu, Long, et al.
Publicado: (2020)

Anemia of Chronic Disease in Patients With Cardiovascular Disease
por: Lanser, Lukas, et al.
Publicado: (2021)

Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients
por: Knell, Astrid I., et al.
Publicado: (2023)

Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure
por: Kurz, Katharina, et al.
Publicado: (2020)

Implications of LDH in patients with coronavirus disease 2019 pneumonia
por: Mu, Tong, et al.
Publicado: (2023)

Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications
por: Derosa, Giuseppe, et al.
Publicado: (2021)

Management of Immunity Alteration-Induced Chronic Pain During the Coronavirus Disease-2019 (COVID-19) Pandemic
por: Sun, Wuping, et al.
Publicado: (2020)

Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
por: Wang, Wen-Xin, et al.
Publicado: (2022)

Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019
por: Salazar-García, Marcela, et al.
Publicado: (2022)

Identifying shared genetic loci between coronavirus disease 2019 and cardiovascular diseases based on cross-trait meta-analysis
por: Guo, Hongping, et al.
Publicado: (2022)

Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course
por: Petzer, Verena, et al.
Publicado: (2021)

Prevention, susceptibility, and clinical features of coronavirus disease 2019 in postoperative patients
por: Gao, Yuan, et al.
Publicado: (2020)

Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study
por: Pereyra, David, et al.
Publicado: (2021)

Surveillance, epidemiology, and impact of the coronavirus disease 2019 interventions on the incidence of enterovirus infections in Nanchang, China, 2010–2022
por: Zhou, Xianfeng, et al.
Publicado: (2023)

Strategies for the prevention and management of coronavirus disease 2019
por: Guan, Wei-jie, et al.
Publicado: (2020)

The role of traditional Chinese medicine in the prevention and treatment of coronavirus disease 2019
por: Yao, Chensi, et al.
Publicado: (2022)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Kaposi’s Sarcoma-Associated Herpesvirus, but Not Epstein-Barr Virus, Co-infection Associates With Coronavirus Disease 2019 Severity and Outcome in South African Patients
por: Blumenthal, Melissa J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_75066vfo2hglvep0pq41mj5eli